LinkedIn
Areas of specialization
-BioTech and Life Sciences
-Business Operations
-Product Development
-Systematic Innovation
----
Dr. Anthony Marotta, Ph.D. is a serial entrepreneur and a proven scientific and clinical leader whom also has a very strong business and operational acumen which is key in delivering shareholder value. As part of his professional tenure, Marotta has co-founded companies including Augurex Life Sciences Corp and Peqish Group and has been a business and clinical advisor for various companies including DueNorth BioDev, Network Immunology and SignalChem Life Sciences Corp.
During Marotta’s eleven-year tenure at Augurex he was responsible for the development of the 14-3-3η biomarker programs, and the successful approvals and launching of the blood tests in Canada, Europe, Australia and United States. At Peqish, Marotta has played a critical role in assisting the business in differentiating itself from other food vendors centered on the concept that “food is medicine”. Marotta has also been key in assisting the Peqish team to operationalise business processes and achieve double digit profitability on EBIDTA.
Prior to Augurex and Peqish, Marotta served as the Director of Business Development for Stressgen Bioreagents where he tactically grew the product portfolio by 30% through developing strategic collaborations. He also played a key role in training lab, sales and technical staff and was involved in several aspects of the day-to-day operations of the whole business.
Marotta holds several patents, has co-authored, and presented at various international conferences, and has strong relationships with clinicians worldwide. Marotta began his career in research at Kinetek Pharmaceuticals whilst pursuing his Ph.D. in Experimental Medicine at the University of British Columbia.
